一项基于全球人口的研究,研究了胺和抽胺与自杀倾向之间的关联,使用了世卫组织的VigiBase
Angela T H Kwan1,2, Moiz Lakhani1,2, Joshua D Rosenblat2,3
1Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
The Journal of clinical psychiatry
|July 10, 2025
概括
胺类药物和胺类药物对报告的自杀倾向有不同的影响. 虽然埃斯基他明与增加自杀念头有关,但在药物监督研究中,这两种药物与自杀未遂和完成自杀的报告率较低有关.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 胺和胺因其快速抗抑郁作用而闻名.
- 它们对自杀倾向的影响,包括潜在的恶化,需要进一步调查.
研究的目的:
- 分析与胺和胺相关的自杀报告.
- 评估这些药物是否与自杀倾向的出现或恶化有关.
主要方法:
- 全球观察性药监队列研究.
- 利用了世界卫生组织的VigiBase数据 (开始至2024年1月).
- 使用报告几率比率 (ROR) 评估不成比例,P < .05显著性.
主要成果:
- 埃斯凯特胺在自杀念头方面显示出较高的不成比例,而不是和素.
- 与相比,胺对自杀念头,自杀企图和完成自杀的不成比例性较低.
- 胺类药物和胺类药物对自杀未遂和完成自杀的概率比参考药物更低.
结论:
- 报告自杀性参数的几率比率增加和减少都被观察到与氨酸和氨酸.
- 当使用或素作为参考时,结果是一致的.
- ketamine/esketamine使用与自杀倾向的变化之间的因果关系无法确定.
更多相关视频
相关概念视频
Pharmacovigilance
999
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
999
Electroconvulsive Therapy
200
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
200
Antiepileptic Drugs: Potassium Channel Activators
283
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
283
Antidepressant Drugs: MAOIs and Other Agents
373
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
373
Depressive Disorders: Etiology
173
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
173


